Fast Five Quiz: Are You Prepared to Confront Metastatic Breast Cancer?

Winston W. Tan, MD


December 21, 2021

Endocrine therapy is routinely recommended as first-line treatment for patients who have hormone receptor (ER and/or progesterone receptor)-positive disease without life-threatening disease or systemic symptoms requiring immediate palliation for comfort. Although higher response rates are achieved with chemotherapy, the incidence of potentially debilitating and serious toxicity is also increased, and there is no evidence that patients live longer because of receiving initial chemotherapy. Treatment could include fulvestrant alone or in combination with aromatase inhibitors or fulvestrant with CDK 4/6 inhibitors.

Learn more about the management of metastatic breast cancer.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.